Congenica showcased in Genomics Spotlight 2024 Report
We are thrilled to announce that Congenica is one of the companies showcased in the recently launched Genomics Spotlight 2024 report produced by the UK Department for Business and Trade (DBT).
Congenica Named Best Genomic Data Analysis Software Company 2024 by GHP
We are thrilled to announce that Congenica has been awarded the title of "Best Genomic Data Analysis Software Company 2024" by Global Health & Pharma Magazine.
Congenica selected for final phase of Instand-NGS4P
Congenica has been selected for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology.
Congenica secures new two-year contract with Hong Kong Genome Project
Congenica announces a two-year extension to their contract with the Hong Kong Genome Project (HKGP).
Congenica and myTomorrows announce partnership to advance Precision Oncology by facilitating rapid access to clinical trials
Congenica and myTomorrows have partnered to expedite access to precision oncology for cancer patients worldwide.
Congenica co-founder Professor Richard Durbin awarded the 39th International Prize for Biology
Congenica Informatics Director Richard Durbin has been awarded the International Prize for Biology by the Japan Society of the Promotion of Science.
Congenica and NoorDx deliver sample-to-report services across the Middle East
Congenica announces a strategic partnership with NoorDx, an innovative clinical genomics and research services company in Saudi Arabia.
The art of genomic winnowing - there is still much to do to unlock the full potential of precision oncology
Philip Beer presented a webinar exploring one of the key challenges that we are currently facing when applying genomic testing in cancer.
The time has come to change the way we treat cancer
Professor Andrew Biankin shares his experiences in transforming cancer care with genomic testing.
The Road to Diagnosis: How Genetics Transforms the Lives of Rare Disease Patients
In recognition of Rare Disease Day, Congenica looks at the importance of a genetic diagnosis for patients and asks, what's next for rare disease?
Congenica co-founder Professor Matt Hurles appointed as Director of the Wellcome Sanger Institute
Co-founder and Scientific Director at Congenica, Professor Matt Hurles, has today been appointed as Director of The Wellcome Trust Sanger Institute.
What’s it like to be a woman working in science?
For International Day of Women and Girls in Science, we talk to three women at Congenica about their experiences of working in STEM.